HEALTH: Humanoid Evaluation and Learning Trial in Coalition-Aligned Healthcare Settings
Trial Snapshot
- Phase
- Phase 2
- Status
- Enrolling By Invitation
- Sponsor
- Enrollment
- 400
- Locations
- 4
- Primary Endpoint
- Biometric Audit Score ≥85 Across Five Performance Dimensions
Study Overview
Brief Summary
This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.
Detailed Description
The HEALTH trial (Humanoid Evaluation and Learning Trial in Healthcare) is a coalition-aligned clinical study designed to assess the deployment of humanoid robotics in real-world care environments. Conducted across metro facilities in New York, Austin, Frankfurt, and Tokyo, the trial evaluates robotic performance in patient intake, sanitation, mobility assistance, and ESG-linked operations.
Humanoid units are enhanced through biotech integration, including skin cell regeneration dips and stem cell neural augmentation. Each unit is tracked via biometric audit scoring across five dimensions: motor function, cognitive response, ESG compliance, biotech retention, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard.
Wage tokens (HumanoidWage, HMW) are minted based on performance thresholds and distributed through smart contracts to deployed units. FX arbitrage across Tokyo and Frankfurt informs reinvestment logic and 1031 exchange-backed yield farming pools. DAO voting governs deployment, wage calibration, and protocol expansion.
This trial aims to establish scalable, transparent frameworks for humanoid integration in healthcare, anchored in coalition governance, public oversight, and metro-ready infrastructure.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- None
Masking Description
N/A - All stakeholders, including facility managers, auditors, and coalition observers, are aware of humanoid deployment and performance tracking.
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •- Age 18-75 years
- •Able to provide informed consent
- •Facility staff, clinical auditors, ESG observers, or coalition stakeholders
- •Willing to interact with humanoid robotics in clinical workflows
- •Available for biometric feedback and observational logging over 90 days
Exclusion Criteria
- •- Cognitive impairment preventing informed consent
- •Active infectious disease requiring isolation
- •Prior adverse reaction to biotech-enhanced robotics
- •Involvement in conflicting clinical trials
- •Inability to comply with protocol procedures or coalition transparency requirements
Arms & Interventions
New York Facility - Skin Cell Deployment
Humanoid units deployed in patient intake and sanitation roles. Enhanced with keratinocyte-based skin cell dips to improve tactile sensitivity and surface regeneration.
Assigned Roles: Intake assistant, sanitation technician
Biometric Focus: Motor function, ESG compliance
Intervention: Skin Cell Dip (Biological)
Austin Facility - Stem Cell Cognitive Enhancement
Humanoid units deployed in mobility and R&D support roles. Enhanced with iPSC-derived stem cell dips targeting neural responsiveness and adaptive learning.
Assigned Roles: Mobility assistant, lab technician
Biometric Focus: Cognitive response, biotech retention
Intervention: Stem Cell Dip (Biological)
Frankfurt Facility - ESG Optimization
Humanoid units deployed in ESG-linked sanitation and logistics roles. Monitored for energy usage, carbon offset, and protocol adherence.
Assigned Roles: ESG sanitation, logistics handler
Biometric Focus: ESG compliance, human interaction
Intervention: ESG Compliance Monitoring, Operational protocol (Behavioral)
Tokyo Facility - Wage Token Calibration
Humanoid units deployed in public interface and intake roles. Wage tokens minted based on biometric audit scores and task completion.
Assigned Roles: Receptionist, intake coordinator
Biometric Focus: Wage token distribution, interaction scoring
Intervention: Wage Token Distribution (Other)
Outcomes
Primary Outcomes
Biometric Audit Score ≥85 Across Five Performance Dimensions
Time Frame: Measured at Day 30 Post-Deployment
This outcome assesses the performance of humanoid robotics units deployed in coalition-aligned healthcare settings. Each unit is scored across five biometric dimensions: motor function, cognitive response, ESG compliance, biotech integration, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard. Units achieving a composite score ≥85 are eligible for wage token bonuses, dip protocol expansion, and DAO-backed facility scaling.
Secondary Outcomes
- ESG Audit Compliance Score ≥90(Humanoid units are evaluated for ESG-linked performance including energy usage, sanitation protocol adherence, and carbon offset metrics. Scores are published to the coalition dashboard and notarized via SHA-256. Units scoring ≥90 contribute to DAO-backe)
- Wage Token Distribution Volume per Unit(Continuous Monitoring Over 90 Days)
- Clinical Workflow Efficiency Increase ≥15%(Measured at Day 90 Post-Deployment)